Eupraxia Pharmaceuticals (EPRX) Property, Plant & Equipment (Net) (2022 - 2026)
Eupraxia Pharmaceuticals (EPRX) Property, Plant & Equipment (Net) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,071.81 Bn | - | 642,333.36 |
| 2 | Nanobiotix | 1,925.70 Bn | 1,925.64 Bn | - | 5.32 Mn |
| 3 | Akari Therapeutics | 1,062.88 Bn | 1,062.88 Bn | - | - |
| 4 | BeOne Medicines | 469.09 Bn | 464.29 Bn | 1.35 Bn | 1.64 Bn |
| 5 | Vertex Pharmaceuticals | 123.09 Bn | 115.84 Bn | 2.59 Bn | 1.61 Bn |
| 6 | Regeneron Pharmaceuticals | 70.32 Bn | 61.57 Bn | 3.31 Bn | 5.27 Bn |
| 7 | Belite Bio | 63.36 Bn | 63.36 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.71 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Alnylam Pharmaceuticals | 37.69 Bn | 34.68 Bn | 959.66 Mn | 518.26 Mn |
| 10 | Eupraxia Pharmaceuticals | 344.48 Mn | 344.48 Mn | - | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.16 Mn |
| Mar 31, 2026 | 1.16 Mn |
| Dec 31, 2025 | 834,429.00 |
| Dec 31, 2025 | 834,429.00 |
| Sep 30, 2025 | 682,835.00 |
| Sep 30, 2025 | 682,835.00 |
| Jun 30, 2025 | 655,578.00 |
| Jun 30, 2025 | 655,578.00 |
| Mar 31, 2025 | 497,282.00 |
| Mar 31, 2025 | 497,282.00 |
| Dec 31, 2024 | 357,893.00 |
| Dec 31, 2024 | 357,893.00 |
| Sep 30, 2024 | 370,004.00 |
| Sep 30, 2024 | 370,004.00 |
| Jun 30, 2024 | 347,422.00 |
| Jun 30, 2024 | 347,422.00 |
| Mar 31, 2024 | 381,731.00 |
| Mar 31, 2024 | 381,731.00 |
| Dec 31, 2023 | 409,587.00 |
| Dec 31, 2023 | 409,587.00 |